Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.02.2023 | Case report

Azd-1222

Vaccine-induced thrombotic thrombocytopenia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Geevar T, et al. Comparison of five different PF4 dependant immunoassays in the diagnosis of vaccine-induced thrombotic thrombocytopenia (VITT). Research and Practice in Thrombosis and Haemostasis 6 (Suppl. 1): no pagination, Oct 2022. Available from: URL: http://doi.org/10.1002/rth2.12788 [abstract] Geevar T, et al. Comparison of five different PF4 dependant immunoassays in the diagnosis of vaccine-induced thrombotic thrombocytopenia (VITT). Research and Practice in Thrombosis and Haemostasis 6 (Suppl. 1): no pagination, Oct 2022. Available from: URL: http://​doi.​org/​10.​1002/​rth2.​12788 [abstract]
Metadaten
Titel
Azd-1222
Vaccine-induced thrombotic thrombocytopenia: case report
Publikationsdatum
01.02.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-33660-z

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Ocrelizumab

Case report

Tozinameran

Case report

AZD-1222